Glaxo projects sales boost from shingles vaccine

Glaxo projects sales boost from shingles vaccine

GlaxoSmithKline (GSK) forecast that 2019 sales of its shingles vaccine would be more than £1bn (€1.1bn) but the drugmaker’s shares slipped on concerns about its pharmaceutical business and free cash flow.

Shingrix, the shingles vaccine launched in 2017, is an important source of growth for chief executive Emma Walmsley, as she strives to improve GSK’s commercial performance after streamlining its operations and spinning off or selling units.

“Shingrix has delivered another fantastic performance in the quarter,” Ms Walmsley said on a media call.

The company said it expected sales of the vaccine to be “significantly” more than £1bn in 2019.

GSK employs around 1,700 people in Dungarvan, Cork and Dublin, but is in the process of closing s site in Sligo.

Glaxo projects sales boost from shingles vaccine

The strength in its vaccines unit, whose sales rose 20% in the quarter to the end of March, comes at a time when some of GSK’s major drugs face generic competition.

Ms Walmsley, who took over as CEO of GSK in 2017, has been looking to reenergise the drugmaker’s pharmaceutical business, its biggest unit, buying US cancer specialist Tesaro for $5.1bn (€4.5bn) and giving it a presence in the oncology market.

“They are really refocusing into oncology and that’s going to take some time — to make that transition — so I think its going to be a difficult time for the pharma business,” said John Rountree, a partner at Novasecta, a biopharma consulting firm, adding that the vaccine business is growing.

GSK shares closed almost 1% lower, with traders pointing to the company’s respiratory drug sales, which came in at £631m, below analysts’ estimate of £651m. 

Also, weighing on the stock was a 50% drop in free cash flow.

- Reuters

More on this topic

Government bid to end anti-vaccination mythsGovernment bid to end anti-vaccination myths

Make vaccinations mandatory: Let’s face down flawed thinkingMake vaccinations mandatory: Let’s face down flawed thinking

Widespread HPV vaccination programmes ‘could eliminate cervical cancer’Widespread HPV vaccination programmes ‘could eliminate cervical cancer’

Irish trust in vaccines below global average, report findsIrish trust in vaccines below global average, report finds

More in this Section

Government to consider legal right for workers to switch off outside working hoursGovernment to consider legal right for workers to switch off outside working hours

Trump’s desire to acquire Greenland is not ‘crazy’Trump’s desire to acquire Greenland is not ‘crazy’

Consumer confidence flashes red for TrumpConsumer confidence flashes red for Trump

Apple €13bn tax appeal hearing next monthApple €13bn tax appeal hearing next month


Lifestyle

Incarcerated in Auschwitz and other Nazi death camps Zuzana Ruzickova somehow survived and went on to create the complete recordings of her beloved Bach, writes James Lawless.Book review: Nazi horrors replaced by brutal Soviets for piano player

The Menu was delighted to make recent mention of a new UCC postgraduate diploma in Irish food culture and is equally pleased to announce availability of two new bursaries for same.The Menu: Food news with Joe McNamee

Milky skincare ingredients keep skin fresh and often suit the whole family, it’s moo-vellous, writes Rachel Marie Walsh.Product watch: Milky skincare ingredients for the whole family

George Orwell’s classic novel foretold a lot, but the manner in which we’ve handed over our personal data to faceless corporatocracies is doubleplus-ungood, says Suzanne Harrington.How we sleepwalked into George Orwell’s nightmarish vision

More From The Irish Examiner